HER2-Positive Metastatic Breast Cancer - A Managed Care Perspective on Emerging Therapies and Clinical Data
Regional Chapter Meeting
1250 Prospect St, La Jolla, CA 92037
Educational Objectives
• Illustrate the evolving landscape of HER2-positive metastatic breast cancer, including current standards of care and emerging sequencing strategies relevant to managed care decision-making.
• Analyze recent clinical trial evidence and evolving HER2-targeted therapies to guide evidence-based formulary development and population health management.
• Assess the implications of new treatment data on access, affordability, and care delivery models to support optimal utilization and equitable outcomes in HER2-positive mBC.
Supported by independent educational grants from AstraZeneca and Daiichi Sankyo.
Activity Disclaimer
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.
Educational Disclaimer
Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Pharmacy Times Office of Continuing Professional Education, LLC. | 259 Prospect Plains Rd, Bldg H | Monroe, NJ 08831
Privacy Policy | Terms & Conditions | Educational Disclaimer | Activity Disclaimer | Contact Us
© Pharmacy Times Office of Continuing Professional Education, LLC. 2025. All Rights Reserved